CMC Icos Biologics, a contract manufacturer of biotech drugs in Bothell, WA, has cut 11 jobs, or about 7.5 percent of its workforce, a company spokesman confirmed. CMC Icos will now have about 130 employees. It’s the second recent sign of hunkering down at CMC Icos: last month it said it is postponing plans to double its manufacturing capacity, because of the recession. The cuts have been added to the updated Seattle tracker, which you can read here.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
